首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1451431

2024-2032 年按塗層、藥物、支架平台、生成、應用、最終用戶和地區分類的藥物洗脫支架市場報告

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球藥物洗脫支架市場規模達83億美元。展望未來， IMARC Group預計到2032年市場規模將達到137億美元，2024-2032年複合年成長率（CAGR）為5.51%。

藥物洗脫支架 (DES) 是一種冠狀動脈裝置，用於在周邊或冠狀動脈中緩慢釋放藥物，以阻止細胞增殖並促進健康的血液流動。它由金屬支架、聚合物塗層和抗再狹窄藥物組成。支架上塗有藥物，有助於動脈保持暢通並確保足夠的血流。 DES 廣泛用於治療心臟動脈阻塞、防止斑塊堆積、血栓並減少反覆血管重建。此支架是微創 (MI) 的，可降低再狹窄率、增強血管癒合並減少長期雙重抗血小板治療的需要。

藥物洗脫支架市場趨勢：

容易患慢性疾病的老年人口不斷增加是推動市場成長的關鍵因素之一。 DES 廣泛用於患有動脈疾病的高風險患者，因為支架有助於減少冠狀動脈繞道手術等侵入性手術的需求。此外，由於大眾不健康的飲食習慣、缺乏體力活動和久坐的生活方式，心血管疾病的盛行率不斷上升，有利於市場的成長。此外，各種技術進步，例如生物可吸收支架的推出，正在推動市場成長。這些支架很容易在體內溶解，並降低支架血栓的風險。與此一致的是，無聚合物塗層支架的廣泛採用對市場成長產生了積極影響。這些支架表現出更高的載藥能力和更快的藥物洗脫速率。其他因素，包括異常心律、心臟衰竭和心臟病發作的發病率上升，以及大眾對 MI 技術的需求不斷增加，預計將推動市場成長。

本報告回答的關鍵問題

2023年全球藥物洗脫支架市場規模有多大？
2024-2032年全球藥物洗脫支架市場的預期成長率是多少？
推動全球藥物洗脫支架市場的關鍵因素是什麼？
COVID-19對全球藥物洗脫支架市場有何影響？
基於塗層的全球藥物洗脫支架市場格局如何？
基於支架平台的全球藥物洗脫支架市場區隔如何？
根據應用，全球藥物洗脫支架市場的細分如何？
根據最終用戶，全球藥物洗脫支架市場的細分如何？
全球藥物洗脫支架市場的重點區域有哪些？
全球藥物洗脫支架市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 13 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 14 章：價值鏈分析

第 15 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 16 章：價格分析

第17章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- B. Braun Melsungen AG
- Biosensors International Group Ltd.
- Biotronik
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC (Cook Group Incorporated)
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic plc
- MicroPort Scientific Corporation
- Sino Medical Sciences Technology Inc.
- Terumo Corporation

簡介目錄圖表

Product Code: SR112024A4815

The global drug-eluting stents market size reached US$ 8.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.51% during 2024-2032.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

Polymer Based Coating

Polymer Free Coating

Breakup by Drug:

Sirolimus

Paclitaxel

Zotarolimus

Everolimus

Biolimus

Others

Breakup by Stent Platform:

Stainless-steel

Cobalt-Chromium

Platinum-Chromium

Nitinol

Others

Breakup by Generation:

1st Generation

2nd Generation

3rd Generation

4th Generation

Breakup by Application:

Coronary Artery Disease

Peripheral Artery Disease

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global drug-eluting stents market in 2023?
2. What is the expected growth rate of the global drug-eluting stents market during 2024-2032?
3. What are the key factors driving the global drug-eluting stents market?
4. What has been the impact of COVID-19 on the global drug-eluting stents market?
5. What is the breakup of the global drug-eluting stents market based on the coating?
6. What is the breakup of the global drug-eluting stents market based on the stent platform?
7. What is the breakup of the global drug-eluting stents market based on the application?
8. What is the breakup of the global drug-eluting stents market based on the end user?
9. What are the key regions in the global drug-eluting stents market?
10. Who are the key players/companies in the global drug-eluting stents market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Drug-Eluting Stents Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Coating

6.1 Polymer Based Coating
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Polymer Free Coating
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug

7.1 Sirolimus
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Paclitaxel
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Zotarolimus
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Everolimus
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Biolimus
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Stent Platform

8.1 Stainless-steel
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cobalt-Chromium
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Platinum-Chromium
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Nitinol
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Generation

9.1 1st Generation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 2nd Generation
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 3rd Generation
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 4th Generation
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Application

10.1 Coronary Artery Disease
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Peripheral Artery Disease
- 10.2.1 Market Trends
- 10.2.2 Market Forecast

11 Market Breakup by End User

11.1 Hospitals
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast

12 Market Breakup by Region

12.1 North America
- 12.1.1 United States
  - 12.1.1.1 Market Trends
  - 12.1.1.2 Market Forecast
- 12.1.2 Canada
  - 12.1.2.1 Market Trends
  - 12.1.2.2 Market Forecast
12.2 Asia-Pacific
- 12.2.1 China
  - 12.2.1.1 Market Trends
  - 12.2.1.2 Market Forecast
- 12.2.2 Japan
  - 12.2.2.1 Market Trends
  - 12.2.2.2 Market Forecast
- 12.2.3 India
  - 12.2.3.1 Market Trends
  - 12.2.3.2 Market Forecast
- 12.2.4 South Korea
  - 12.2.4.1 Market Trends
  - 12.2.4.2 Market Forecast
- 12.2.5 Australia
  - 12.2.5.1 Market Trends
  - 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
  - 12.2.6.1 Market Trends
  - 12.2.6.2 Market Forecast
- 12.2.7 Others
  - 12.2.7.1 Market Trends
  - 12.2.7.2 Market Forecast
12.3 Europe
- 12.3.1 Germany
  - 12.3.1.1 Market Trends
  - 12.3.1.2 Market Forecast
- 12.3.2 France
  - 12.3.2.1 Market Trends
  - 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
  - 12.3.3.1 Market Trends
  - 12.3.3.2 Market Forecast
- 12.3.4 Italy
  - 12.3.4.1 Market Trends
  - 12.3.4.2 Market Forecast
- 12.3.5 Spain
  - 12.3.5.1 Market Trends
  - 12.3.5.2 Market Forecast
- 12.3.6 Russia
  - 12.3.6.1 Market Trends
  - 12.3.6.2 Market Forecast
- 12.3.7 Others
  - 12.3.7.1 Market Trends
  - 12.3.7.2 Market Forecast
12.4 Latin America
- 12.4.1 Brazil
  - 12.4.1.1 Market Trends
  - 12.4.1.2 Market Forecast
- 12.4.2 Mexico
  - 12.4.2.1 Market Trends
  - 12.4.2.2 Market Forecast
- 12.4.3 Others
  - 12.4.3.1 Market Trends
  - 12.4.3.2 Market Forecast
12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast

13 SWOT Analysis

13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
  - 17.3.1.1 Company Overview
  - 17.3.1.2 Product Portfolio
  - 17.3.1.3 Financials
  - 17.3.1.4 SWOT Analysis
- 17.3.2 B. Braun Melsungen AG
  - 17.3.2.1 Company Overview
  - 17.3.2.2 Product Portfolio
  - 17.3.2.3 SWOT Analysis
- 17.3.3 Biosensors International Group Ltd.
  - 17.3.3.1 Company Overview
  - 17.3.3.2 Product Portfolio
- 17.3.4 Biotronik
  - 17.3.4.1 Company Overview
  - 17.3.4.2 Product Portfolio
  - 17.3.4.3 SWOT Analysis
- 17.3.5 Boston Scientific Corporation
  - 17.3.5.1 Company Overview
  - 17.3.5.2 Product Portfolio
  - 17.3.5.3 Financials
  - 17.3.5.4 SWOT Analysis
- 17.3.6 Cardinal Health Inc.
  - 17.3.6.1 Company Overview
  - 17.3.6.2 Product Portfolio
  - 17.3.6.3 Financials
  - 17.3.6.4 SWOT Analysis
- 17.3.7 Cook Medical LLC (Cook Group Incorporated)
  - 17.3.7.1 Company Overview
  - 17.3.7.2 Product Portfolio
  - 17.3.7.3 SWOT Analysis
- 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
  - 17.3.8.1 Company Overview
  - 17.3.8.2 Product Portfolio
  - 17.3.8.3 Financials
- 17.3.9 Medtronic plc
  - 17.3.9.1 Company Overview
  - 17.3.9.2 Product Portfolio
  - 17.3.9.3 Financials
  - 17.3.9.4 SWOT Analysis
- 17.3.10 MicroPort Scientific Corporation
  - 17.3.10.1 Company Overview
  - 17.3.10.2 Product Portfolio
- 17.3.11 Sino Medical Sciences Technology Inc.
  - 17.3.11.1 Company Overview
  - 17.3.11.2 Product Portfolio
- 17.3.12 Terumo Corporation
  - 17.3.12.1 Company Overview
  - 17.3.12.2 Product Portfolio
  - 17.3.12.3 Financials
  - 17.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2023
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2023
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2023
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2023
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2023
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2023
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2023
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2023
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2024-2032
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2024-2032
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2024-2032
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2024-2032
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players

02-2729-4219

+886-2-2729-4219